These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 11552908)
21. Pantoprazole and omeprazole in the treatment of reflux oesophagitis: a European multicentre study. Corinaldesi R; Valentini M; Belaïche J; Colin R; Geldof H; Maier C Aliment Pharmacol Ther; 1995 Dec; 9(6):667-71. PubMed ID: 8824655 [TBL] [Abstract][Full Text] [Related]
22. Efficacy and tolerability of 20 mg pantoprazole versus 300 mg ranitidine in patients with mild reflux-oesophagitis: a randomized, double-blind, parallel, and multicentre study. van Zyl JH; de K Grundling H; van Rensburg CJ; Retief FJ; O'Keefe SJ; Theron I; Fischer R; Bethke T Eur J Gastroenterol Hepatol; 2000 Feb; 12(2):197-202. PubMed ID: 10741935 [TBL] [Abstract][Full Text] [Related]
23. Comparable clinical efficacy and tolerability of 20 mg pantoprazole and 20 mg omeprazole in patients with grade I reflux oesophagitis. Bardhan KD; Van Rensburg C Aliment Pharmacol Ther; 2001 Oct; 15(10):1585-91. PubMed ID: 11563998 [TBL] [Abstract][Full Text] [Related]
24. Esomeprazole 20 mg vs. pantoprazole 20 mg for maintenance therapy of healed erosive oesophagitis: results from the EXPO study. Labenz J; Armstrong D; Lauritsen K; Katelaris P; Schmidt S; Schütze K; Wallner G; Juergens H; Preiksaitis H; Keeling N; Nauclér E; Adler J; Eklund S Aliment Pharmacol Ther; 2005 Nov; 22(9):803-11. PubMed ID: 16225489 [TBL] [Abstract][Full Text] [Related]
25. Pantoprazole. Poole P Am J Health Syst Pharm; 2001 Jun; 58(11):999-1008. PubMed ID: 11402494 [TBL] [Abstract][Full Text] [Related]
26. Pantoprazole 20 mg is an effective maintenance therapy for patients with gastro-oesophageal reflux disease. Plein K; Hotz J; Wurzer H; Fumagalli I; Lühmann R; Schneider A Eur J Gastroenterol Hepatol; 2000 Apr; 12(4):425-32. PubMed ID: 10783996 [TBL] [Abstract][Full Text] [Related]
28. Pantoprazole 20 mg is effective for relief of symptoms and healing of lesions in mild reflux oesophagitis. Dettmer A; Vogt R; Sielaff F; Lühmann R; Schneider A; Fischer R Aliment Pharmacol Ther; 1998 Sep; 12(9):865-72. PubMed ID: 9768529 [TBL] [Abstract][Full Text] [Related]
29. [Clinical superiority of pantoprazole over ranitidine in the treatment of reflux esophagitis grade II and III. A prospective, double-blind, double-placebo study. Mexican clinical experience. Mexican Pantoprazole Study Group]. Gallo S; Dibildox M; Moguel A; Di Silvio M; Rodríguez F; Almaguer I; García C Rev Gastroenterol Mex; 1998; 63(1):11-6. PubMed ID: 10068743 [TBL] [Abstract][Full Text] [Related]
30. Role of pantoprazole in the treatment of gastro-oesophageal reflux disease. Lehmann FS; Beglinger C Expert Opin Pharmacother; 2005 Jan; 6(1):93-104. PubMed ID: 15709887 [TBL] [Abstract][Full Text] [Related]
31. The basis for the decreased response to proton pump inhibitors in gastro-oesophageal reflux disease patients without erosive oesophagitis. Gardner JD; Gallo-Torres H; Sloan S; Robinson M; Miner PB Aliment Pharmacol Ther; 2003 Nov; 18(9):891-905. PubMed ID: 14616153 [TBL] [Abstract][Full Text] [Related]
32. A double-blind study of pantoprazole and omeprazole in the treatment of reflux oesophagitis: a multicentre trial. Mössner J; Hölscher AH; Herz R; Schneider A Aliment Pharmacol Ther; 1995 Jun; 9(3):321-6. PubMed ID: 7654895 [TBL] [Abstract][Full Text] [Related]
33. Short- and long-term therapy for reflux oesophagitis in the elderly: a multi-centre, placebo-controlled study with pantoprazole. Pilotto A; Leandro G; Franceschi M; Aliment Pharmacol Ther; 2003 Jun; 17(11):1399-406. PubMed ID: 12786634 [TBL] [Abstract][Full Text] [Related]
34. Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux disease. Castell D; Bagin R; Goldlust B; Major J; Hepburn B Aliment Pharmacol Ther; 2005 Jun; 21(12):1467-74. PubMed ID: 15948814 [TBL] [Abstract][Full Text] [Related]
35. Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs. Langtry HD; Wilde MI Drugs; 1998 Sep; 56(3):447-86. PubMed ID: 9777317 [TBL] [Abstract][Full Text] [Related]
36. Short-term therapeutic trial of proton pump inhibitors in suspected extraesophageal reflux. Habermann W; Kiesler K; Eherer A; Friedrich G J Voice; 2002 Sep; 16(3):425-32. PubMed ID: 12395996 [TBL] [Abstract][Full Text] [Related]
37. Comparable efficacy of pantoprazole and omeprazole in patients with moderate to severe reflux esophagitis. Results of a multinational study. Körner T; Schütze K; van Leendert RJ; Fumagalli I; Costa Neves B; Bohuschke M; Gatz G Digestion; 2003; 67(1-2):6-13. PubMed ID: 12743434 [TBL] [Abstract][Full Text] [Related]
38. Treatment of oesophageal bile reflux in children: the results of a prospective study with omeprazole. Orel R; Brecelj J; Homan M; Heuschkel R J Pediatr Gastroenterol Nutr; 2006 Apr; 42(4):376-83. PubMed ID: 16641575 [TBL] [Abstract][Full Text] [Related]
39. Early relief of upper gastrointestinal dyspeptic symptoms: a survey of empirical therapy with pantoprazole in Canadian clinical practice. Armstrong D; Kazim F; Gervais M; Pyzyk M Can J Gastroenterol; 2002 Jul; 16(7):439-50. PubMed ID: 12177723 [TBL] [Abstract][Full Text] [Related]
40. Efficacy and tolerability of pantoprazole 40 mg versus 80 mg in patients with reflux oesophagitis. van Rensburg CJ; Honiball PJ; Grundling HD; van Zyl JH; Spies SK; Eloff FP; Simjee AE; Segal I; Botha JF; Cariem AK; Marks IN; Theron I; Bethke TD Aliment Pharmacol Ther; 1996 Jun; 10(3):397-401. PubMed ID: 8791969 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]